Literature DB >> 4551988

2. Improvement criteria in drug trials with neurotic patients.

R Kellner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4551988     DOI： 10.1017/s0033291700045645

Source DB:  PubMed          Journal:  Psychol Med        ISSN： 0033-2917            Impact factor:   7.723


× No keyword cloud information.
  5 in total

1.  The assessment of drugs in obsessional states.

Authors:  R Philpott
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

2.  Intensive design in evaluating anxiolytic agents.

Authors:  E H Uhlenhuth; D A Turner; G Purchatzke; T Gift; J Chassan
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

3.  The effects of chlordiazepoxide on self-rated depression, anxiety, and well-being.

Authors:  R Kellner; R T Rada; T Andersen; D Pathak
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

4.  Prolactin, amitriptyline, and recovery from depression.

Authors:  J Lisansky; G A Fava; M T Buckman; R Kellner; M Fava; M Zielezny; G T Peake
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Global clinical response in Cushing's syndrome patients treated with mifepristone.

Authors:  Laurence Katznelson; D Lynn Loriaux; David Feldman; Glenn D Braunstein; David E Schteingart; Coleman Gross
Journal:  Clin Endocrinol (Oxf)       Date:  2013-10-17       Impact factor: 3.478
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.